Document is current
Any future updates will be listed below
-
Authors
Nagano, Nobuo https://orcid.org/0000-0001-6527-3286
Tokunaga, Shin
Asada, Shinji
Fukagawa, Masafumi
Akizawa, Tadao
-
Funding
Funding for this research was provided by:
Kyowa Kirin
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 15 June 2026
First Online: 1 July 2026
Declarations
:
: Nobuo Nagano received consultancies from Kyowa Kirin Co., Ltd.; honoraria from Kyowa Kirin Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Toa Shinyaku Co., Ltd.; Nobelpharma Co., Ltd.; Torii Pharmaceutical Co., Ltd.; and Ono Pharmaceutical Co., Ltd. Shin Tokunaga and Shinji Asada are employees of Kyowa Kirin Co., Ltd. Masafumi Fukagawa received grants from Kyowa Kirin Co., Ltd. to his institution; consulting fees and honoraria from Sanwa Kagaku Kenkyusho Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Kyowa Kirin Co., Ltd.; Bayer Yakuhin, Ltd.; Kissei Pharmaceutical Co., Ltd.; and Torii Pharmaceutical Co., Ltd. Tadao Akizawa received consulting fees from Kyowa Kirin Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Torii Pharmaceutical Co., Ltd.; and Sanwa Kagaku Kenkyusho Co., Ltd.; honoraria from Kyowa Kirin Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Torii Pharmaceutical Co., Ltd.; and Sanwa Kagaku Kenkyusho Co., Ltd.; support for travel fee from Kyowa Kirin Co., Ltd.
